The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

Clinicians have traditionally used clinicopathological (CP) factors to determine locoregional recurrence (LR) risk of breast cancer and have generated the IBTR! nomogram to predict the risk of ipsilateral breast tumor recurrence (IBTR). The 21-gene recurrence score (RS) assay was recently correlated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Springerplus
Main Authors: Thaker, Nikhil G, Hoffman, Karen E, Stauder, Michael C, Shaitelman, Simona F, Strom, Eric A, Tereffe, Welela, Smith, Benjamin D, Perkins, George H, Huo, Lei, Munsell, Mark F, Pusztai, Lajos, Buchholz, Thomas A, Woodward, Wendy A
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318826/
https://ncbi.nlm.nih.gov/pubmed/25674496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-0840-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados